Keygene
KeyGene is a private Dutch AgBiotech research company, founded in 1989 and owned by four global seed-breeding shareholders, that develops and licenses proprietary genomics, cell-and-tissue, and AI-enabled crop-improvement technologies for vegetable, fruit, ornamental, and industrial crop breeders worldwide.
- Company typePrivate
- Founded1989
- HeadquartersWageningen, Netherlands
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Keygene does
KeyGene is a privately held Dutch AgBiotech research company founded in 1989 and headquartered in Wageningen, with additional R&D operations in Rockville, Maryland, and Hyderabad, India. It operates as a B2B contract research and technology innovation partner serving global vegetable, fruit, ornamental, and industrial crop breeders, as well as licensing customers in healthcare, diagnostics, and biotechnology services. The company is wholly owned by four strategic shareholders — Enza Zaden, Rijk Zwaan, Limagrain Vegetable Seeds (Vilmorin & Cie), and Takii — which simultaneously fund its research programs and act as long-term R&D collaborators.
The company monetizes through three primary streams: (1) technology licensing of its proprietary IP portfolio, including KeyPoint (multiplex genetic-variation detection), 2S1 graft hybrid technology, the PAR gene for apomixis, hormone-free plant regeneration, AFLP, SNPWave, KeySeeQ, CropPedia, ProgressiveSTL, and the PhenoGene breeding optimizer; (2) contract research projects executed for partners; and (3) multi-year strategic R&D collaborations where KeyGene functions as an embedded extension of partner R&D teams. Pricing is bespoke and not publicly disclosed.
KeyGene's technology stack combines DNA/RNA technologies, metabolomics and proteomics, data science and AI, cell and tissue technologies, and trait technologies. Recent platform investments include spatial transcriptomics (Vizgen Merscope), single-nuclei RNA sequencing (10x Genomics Chromium X with Oxford Nanopore long-read integration), an AI-augmented Systems Biology platform for causal trait discovery, automated ultra-high-throughput exome workflows with Twist Bioscience and Beckman Coulter, and T2T genome assembly using Oxford Nanopore duplex sequencing at Q50 accuracy. The technology portfolio is protected by an extensive granted and pending patent estate and was recognized with a #40 ranking in the Netherlands' 2025 R&D Top 50.
Keygene firmographics
Firmographics- Name
- Keygene
- Legal name
- Keygene N.V.
- Website
- https://keygene.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- KeyGene is a private Dutch AgBiotech research company, founded in 1989 and owned by four global seed-breeding shareholders, that develops and licenses proprietary genomics, cell-and-tissue, and AI-enabled crop-improvement technologies for vegetable, fruit, ornamental, and industrial crop breeders worldwide.
- Ownership category
- akta.pro rank
Keygene industry classification
Industry- Product category
- Agricultural Biotechnology Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- Biotechnology & Gene-Edited Trait Development (AFAGAIAG)
- akta.pro secondary industries
- Gene Editing Trait Development (CRISPR/TALEN/ZFN) (AFABALAB), Trait Discovery & Functional Genomics (Target ID/Validation) (AFABALAC), Transformation & Tissue Culture Platforms (Plant regeneration, delivery systems) (AFABALAH)
Keywords
Where Keygene is headquartered
LocationHeadquarters
- HQ city
- Wageningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices3 records
Markets served
Keygene business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Technology Licensing: Licensing of KeyGene's intellectual property including genomics, bioinformatics, cell & tissue culture technologies, and trait technologies to healthcare, biotechnology services, and agro-food sector companies. Favorable conditions apply for not-for-profit research organizations.
- Contract Research: Research projects conducted for partners using KeyGene's expertise and state-of-the-art technologies to solve specific research questions and service needs according to highest quality standards.
- Strategic R&D Collaborations: Long-term multi-year collaborative R&D partnerships where KeyGene works closely as integrated R&D team with partners to reach final objectives, combining strengths of all parties.
- Shareholder Funding: Research largely funded by four international vegetable crop breeding companies (Enza Zaden, Rijk Zwaan, Limagrain Vegetable Seeds, Takii) which are shareholders of KeyGene.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Keygene product offering
Product offeringCore offering
KeyGene is an agricultural biotechnology research company that develops and applies proprietary technology innovations for crop improvement. Its core offerings combine DNA/RNA technology, metabolomics & proteomics, data science/AI, cell & tissue technology, and trait technologies to accelerate plant breeding for vegetables, fruits, ornamentals, and industrial field crops. The company delivers these capabilities to partners through contract research projects, multi-year strategic R&D collaborations, and technology licensing arrangements.
Product overview
KeyGene operates as a research company providing technology innovation for crop improvement, offering a portfolio of proprietary technologies across genomics, data science, and plant biology. The core offerings include DNA/RNA technologies (sequencing, genotyping, genome editing), data science tools (CropPedia, ProgressiveSTL, PhenoGene), cell and tissue technologies (2S1 graft hybrids, hormone-free regeneration), and trait technologies. These are applied for and with partners including vegetable breeders, fruits, ornamentals, and industrial field crops. KeyGene licenses innovations and provides contract research services to healthcare, biotechnology, and agro-food sectors worldwide.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Research Services
- Strategic R&D Collaborations
- Technology Licensing Program
- KeyPoint Breeding Technology
- CropPedia
- ProgressiveSTL
- PhenoGene Breeding Optimizer
- Telomere-to-Telomere Genome Sequencing
- Single-nuclei RNA Sequencing (snRNA-seq)
- Spatial Transcriptomics (Merscope)
- HortControl
- 2S1 Graft Hybrid Technology
- Apomixis Technology
- Hormone-free Plant Regeneration Method
- Single Pollen Nuclei Sequencing
- Automated High-Throughput Plant Exome Workflow
Quantifiable outcome
- First skin-transplant potato variety received plant breeders' rights in Netherlands (March 2025)
- +4 more outcomes
Companies that use Keygene
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles5 records
Keygene technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature11 records
Keygene partnerships and signals
Strategic signalPartnerships
24 partnerships are on record, tiered major and core.
- 10x GenomicsmajorKeyGene developed single-nuclei transcriptomics technology based on Chromium X platform from 10x Genomics for analyzing gene expression profiles at single-cell resolution in plants.
- Oxford Nanopore TechnologiesmajorApplied long-read sequencing technologies alongside short-read sequencing for snRNA-seq libraries, providing additional information on transcript isoforms and their cell-type-specific functional relevance.
- Ultima GenomicsmajorJoint research on single-pollen nuclei sequencing combining KeyGene's protocols with Ultima Genomics UG 100 platform for better understanding of meiotic recombination in plant breeding.
- Twist BiosciencemajorCollaboration on ultra-high throughput workflow for plant exome analysis. Twist Bioscience produced custom lettuce exome capturing probe set for the automated workflow.
- Beckman Coulter Life SciencesmajorCollaboration on automated high-throughput workflow for plant exome analysis. Provided Biomek i7 Dual hybrid workstation with integrated Echo acoustic liquid handler for automated sample processing.
- VizgenmajorKeyGene acquired Vizgen's Merscope platform for spatial transcriptomics, being first organization in Netherlands to deploy this technology for studying plant-pathogen interactions and plant development.
- Heinrich Heine University Düsseldorf (HHU)majorAwarded Marcel van Verk (KeyGene) honorary guest professorship. Partnership with CEPLAS (Cluster of Excellence on Plant Sciences) for scientific exchange and collaborative research. Collaboration also on spatial transcriptomics research.
- CEPLAS (Cluster of Excellence on Plant Sciences)majorPartnership for scientific exchange and collaborative research. CEPLAS member Guido Grossmann initiated the guest professorship for KeyGene's Marcel van Verk. KeyGene co-organizes CropIB with CEPLAS.
- VIBmajorCo-organizer of CROP Innovation & Business (CropIB) 2026 conference alongside CEPLAS and Wageningen University & Research.
- IventusmajorConference organizer for CROP Innovation & Business (CropIB) 2026, organized by Iventus in collaboration with KeyGene, VIB, CEPLAS, and WUR.
- Wageningen University & ResearchcoreMajor research collaborator supporting Yelloway initiative and multiple joint research projects. KeyGene's About page states location in Wageningen, indicating deep ties. Joint research includes hormone-free plant regeneration (published in Plant Cell 2025) and apomixis discovery (Nature Genetics 2022).
- Takara BiomajorCollaboration on single-nucleus RNA sequencing in pollen. Combined Takara Bio's transcriptomics technology with KeyGene's nuclei isolation expertise and pollen-specific gene expression knowledge.
- Phenome NetworksmajorIntegration of KeyGene's breeding optimizer algorithm into PhenomeOne software package as PhenoGene module, making the tool available to thousands of breeders worldwide on SaaS basis.
- University of MilanmajorCollaboration on Georgian grapevine 'Mgaloblishvili' genome sequencing and characterization. Won KeyGene DNA-Day contest 2021, leading to genome publication in Horticulture Research (2025).
- University of California DavismajorCollaboration on Georgian grapevine 'Mgaloblishvili' genome sequencing with University of Milan and KeyGene.
- Leibniz Institute of Plant BiochemistrymajorPart of EU-financed CHIC research project. Joint research on genome editing of chicory for accumulation of costunolide (anti-cancer compound), published in Frontiers in Plant Science 2022.
- MusaRadixcorePartner in Yelloway initiative - joint venture with Chiquita and MusaRadix, supported by Wageningen University & Research, aiming to develop banana varieties resistant to TR4 and Black Sigatoka diseases.
- ChiquitacorePartner in Yelloway initiative - joint venture with MusaRadix and KeyGene, supported by Wageningen University & Research, aiming to develop banana varieties resistant to TR4 and Black Sigatoka diseases. Completed Yelloway banana pan-genome in February 2026.
- Bioseed (DCM Shriram)majorJoint development of hybrid rice lines combining higher yield with good cooking quality for Indian rice farmers. Signing ceremony witnessed by Dutch Prime Minister Mark Rutte in 2023.
- Ball Horticultural CompanymajorSupported accelerated breeding of impatiens resistant to downy mildew. Joint genome sequencing of Impatiens walleriana (2018). Ball Horticultural Company is a major customer and research collaborator.
- Enza ZadencoreStrategic shareholder and long-term R&D partner. Enza Zaden is one of four strategic shareholders that fund KeyGene's research programs. Ranked #24 in Netherlands' 2025 R&D Top 50.
- Rijk ZwaancoreStrategic shareholder and long-term R&D partner. Rijk Zwaan is one of four strategic shareholders that fund KeyGene's research programs. Ranked #12 in Netherlands' 2025 R&D Top 50.
- Limagrain Vegetable Seeds (Vilmorin & Cie)coreStrategic shareholder and long-term R&D partner. Vilmorin & Cie represents Limagrain's vegetable seed operations as one of four strategic shareholders funding KeyGene's research.
- TakiicoreStrategic shareholder and long-term R&D partner. Takii is one of four strategic shareholders funding KeyGene's research programs. Also collaborated on apomixis research published in Nature Genetics 2022.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Keygene competitors and assessment
Company assessmentBroad incumbents
- KWS SAAT: KWS is one of the world's leading plant breeding companies for sugar beet, corn, cereals, and vegetables, with substantial R&D in genomics and trait development. Comparable as a customer-archetype for KeyGene's breeding technology services and a fellow European plant-breeding major.
- Corteva Agriscience: Corteva is a global seed and crop protection company with a major R&D investment in gene editing and predictive breeding. Competes with KeyGene-adjacent capabilities but at vastly greater scale and with proprietary germplasm, representing the incumbent landscape in advanced breeding.
- Syngenta Group: Syngenta is a global agricultural technology company with extensive seed and crop protection businesses and significant investment in crop genomics and breeding. Represents a broad incumbent counterpoint to KeyGene's specialized research and platform licensing model.
- Bayer Crop Science: Bayer Crop Science operates one of the largest agricultural R&D programs globally, with extensive breeding and trait development in row crops and vegetables. KeyGene is a licensee and partner of Bayer for some technologies, and Bayer represents the large-incumbent counterpoint to KeyGene's specialized platform model.
Direct peers
- Benson Hill: Benson Hill applies genomics, AI, and predictive breeding to develop improved crop varieties, particularly soybeans. Comparable to KeyGene's crop improvement platform combining genomics, data science, and proprietary breeding tools for partner breeders.
- Cibus: Cibus develops gene-edited crop traits using its Rapid Trait Development System, focusing on oilseed crops, rice, and wheat. Comparable to KeyGene as a technology-platform provider of crop improvement traits to seed companies, with similar licensing and partnership GTM motions.
- Inari Agriculture: Inari is a SEEDesign company combining AI, multiplex gene editing, and computational biology to develop proprietary seeds for corn, soybean, and wheat. Highly comparable to KeyGene's AI-driven Systems Biology platform and trait discovery focus for major field and vegetable crops.
- Tropic Biosciences: Tropic Biosciences is a UK-based AgBiotech company using gene editing for tropical crops including banana, coffee, and rice. Directly comparable to KeyGene's banana (Yelloway/TR4) and rice (Bioseed) programs and its overall gene-editing R&D services model.
- Pairwise: Pairwise is a US-based AgBiotech company using CRISPR and base editing for crop improvement, directly comparable to KeyGene's gene editing and trait development work in fruits, vegetables, and row crops. Both target similar seed-industry customers with platform-based breeding innovation.
Emerging players
- Hudson River Biotechnology: Hudson River Biotechnology is a Netherlands-based AgBiotech applying CRISPR and nanoparticle delivery for plant trait editing. Comparable as a Dutch peer in crop biotech, though smaller and earlier stage than KeyGene with narrower crop focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Keygene social profiles
Digital presenceKeygene financial estimates
Financial estimateRevenue estimate
Valuation estimate
Keygene leadership team
Management profileNumber of profiles
Profiles13 records
Keygene funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Keygene M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Keygene
What does Keygene do?
KeyGene is an agricultural biotechnology research company that develops and applies proprietary technology innovations for crop improvement. Its core offerings combine DNA/RNA technology, metabolomics & proteomics, data science/AI, cell & tissue technology, and trait technologies to accelerate plant breeding for vegetables, fruits, ornamentals, and industrial field crops. The company delivers these capabilities to partners through contract research projects, multi-year strategic R&D collaborations, and technology licensing arrangements.
Is Keygene a public or private company?
Keygene is a private company. It is classified as corporate owned and is currently operating.
When was Keygene founded?
Keygene was founded in 1989. It employs 51 to 100 people.
Where is Keygene based?
Keygene is headquartered in Wageningen, Netherlands, in the Europe region.
How does Keygene make money?
Four revenue lines are on record. Technology Licensing is the primary driver. The others are contract Research, strategic R&D Collaborations and shareholder Funding.
Who are Keygene's main competitors?
Broad incumbents on record are KWS SAAT, Corteva Agriscience, Syngenta Group and Bayer Crop Science. Direct peers are Benson Hill, Cibus, Inari Agriculture, Tropic Biosciences and Pairwise. Hudson River Biotechnology is listed as an emerging player.
Does Keygene have an API?
No public API is recorded for Keygene.
What industry is Keygene in?
Keygene's product category is Agricultural Biotechnology Research. Its primary akta.pro industry code is AFAGAIAG, Biotechnology & Gene-Edited Trait Development, with a secondary code of AFABALAB, Gene Editing Trait Development (CRISPR/TALEN/ZFN). Its NAICS code is 541714.